Amag Pharmaceuticals Indenture Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to Indenture for 3.25% Convertible Senior Notes due 2022 between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association
Indenture Agreements
Amag Pharmaceuticals
Pharmaceuticals
DE
2017
Third Supplemental Indenture between AMAG Pharmaceuticals, Inc., Covis Finco S.à r.l., and Wilmington Trust, N.A. (November 16, 2020)
Indenture Agreements
Amag Pharmaceuticals
Pharmaceuticals
NY
2020
Second Supplemental Indenture between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (November 16, 2020)
Indenture Agreements
Amag Pharmaceuticals
Pharmaceuticals
NY
2020
Third Supplemental Indenture between AMAG Pharmaceuticals, Inc., Covis Finco S.à r.l., and Wilmington Trust, N.A. (November 16, 2020)
Indenture Agreements
Amag Pharmaceuticals
Pharmaceuticals
NY
2020
Second Supplemental Indenture to 3.25% Convertible Senior Notes Due 2022 between AMAG Pharmaceuticals, Inc. and Wilmington Trust, N.A.
Indenture Agreements
Amag Pharmaceuticals
Pharmaceuticals
NY
2020
Indenture Agreement between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (May 10, 2017)
Indenture Agreements
Amag Pharmaceuticals
Pharmaceuticals
DE
2017
First Supplemental Indenture to Senior Debt Securities Indenture between AMAG Pharmaceuticals, Inc. and Wilmington Trust, N.A. (2.50% Convertible Senior Notes due 2019)
Indenture Agreements
Amag Pharmaceuticals
Pharmaceuticals
DE
2014
Indenture Agreement between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (February 14, 2014)
Indenture Agreements
Amag Pharmaceuticals
Pharmaceuticals
DE
2014